Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report.
作者信息
Llaneza-Suarez Cristina, Eiriz-Eirin Montserrat, Llaneza Placido
机构信息
Xove Centro de Salud, Hospital Da Costa Burela, Camino Real, 0, 27870 Xove, Lugo, Spain.
Universidad de Oviedo, La Merced, 22, 2C, 33201 Oviedo, Gijón, Spain.
出版信息
Case Rep Womens Health. 2020 Apr 21;27:e00206. doi: 10.1016/j.crwh.2020.e00206. eCollection 2020 Jul.
Abstract
Patients with surgical menopause often present to their primary care provider with menopausal symptoms. Here we present an unusual case of palmar arch artery occlusion in a 55-year-old woman with primary Raynaud's disease taking oral combined menopausal hormone therapy after surgical menopause for endometriosis. She was successfully treated with intravenous infusion of prostaglandin E1 and nitroglycerin patches over two weeks. Menopausal hormone therapy was stopped and her vasomotor symptoms did not recur.
摘要
相似文献
1
Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report.
Case Rep Womens Health. 2020 Apr 21;27:e00206. doi: 10.1016/j.crwh.2020.e00206. eCollection 2020 Jul.
2
[Video-thoracoscopic sympathectomy in the treatment of Raynaud's disease and palmar hyperhidrosis].
Minerva Chir. 2000 Jan-Feb;55(1-2):17-23.
3
Role of digital artery adrenoceptors in Raynaud's disease.
Vasc Med. 1997;2(1):1-7. doi: 10.1177/1358863X9700200101.
4
Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Ann Pharmacother. 2007 Sep;41(9):1544-7. doi: 10.1345/aph.1K212. Epub 2007 Jul 31.
5
Bilateral Brachial Artery Disease Presenting with Features of Raynaud's Phenomenon: A Case Report and Review of the Literature.
Case Rep Vasc Med. 2017;2017:7461082. doi: 10.1155/2017/7461082. Epub 2017 Jul 10.
6
Digital arterial occlusion in scleroderma: is there a role for digital arterial reconstruction?
J Hand Surg Br. 2000 Dec;25(6):611-3. doi: 10.1054/jhsb.2000.0439.
7
Lack of habituation of the pattern of cardiovascular response evoked by sound in subjects with primary Raynaud's disease.
Clin Sci (Lond). 1998 Sep;95(3):249-60.
8
A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
Ann Rheum Dis. 1985 Nov;44(11):754-60. doi: 10.1136/ard.44.11.754.
9
[A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
J Mal Vasc. 2010 Feb;35(1):35-7. doi: 10.1016/j.jmv.2009.10.003. Epub 2009 Dec 2.
10
Post-Traumatic Raynaud's Phenomenon: A Case Report.
J Emerg Med. 2017 Jun;52(6):e237-e238. doi: 10.1016/j.jemermed.2017.01.001. Epub 2017 Feb 27.
本文引用的文献
1
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
BMJ. 2019 Jan 9;364:k4810. doi: 10.1136/bmj.k4810.
2
The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause. 2018 Nov;25(11):1362-1387. doi: 10.1097/GME.0000000000001241.
3
A Review of Raynaud's Disease.
Mo Med. 2016 Mar-Apr;113(2):123-6.
4
Surgical Menopause.
Endocrinol Metab Clin North Am. 2015 Sep;44(3):531-42. doi: 10.1016/j.ecl.2015.05.003. Epub 2015 Jun 12.
5
EMAS position statement: The ten point guide to the integral management of menopausal health.
Maturitas. 2015 May;81(1):88-92. doi: 10.1016/j.maturitas.2015.02.003. Epub 2015 Feb 11.
6
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
Climacteric. 2013 Jun;16(3):316-37. doi: 10.3109/13697137.2013.795683.
7
Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Maturitas. 2011 Nov;70(3):261-5. doi: 10.1016/j.maturitas.2011.08.001. Epub 2011 Sep 4.
8
Estrogens and neuropeptides in Raynaud's phenomenon.
Rheum Dis Clin North Am. 2005 Feb;31(1):177-86, x-xi. doi: 10.1016/j.rdc.2004.10.005.
9
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
10
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
Zotero 插件